Skip to main content

Lanxess sets climate-neutrality target

25th November 2019

Submitted by:

Andrew Warmington

Lanxess has set itself a goal of eliminating its greenhouse gas emissions, currently 3.2 million tonnes/year of CO2 equivalent, by 2040. It already had a target of halving them by 2030. This will involve a three-pronged strategy, the company said:

* Launching major ‘impact projects’ for climate protection: currently planned examples include a nitrous oxide decomposition facility, due onstream at Antwerp next year and switching entirely to solar and biomass power at its Indian sites

* Decoupling emissions from growth, partly by means changes to governance, such that the impact on the company’s carbon footprint will becoming an investment criterion for organic growth and acquisitions

* Strengthening process and technological innovation, in areas like heat exchange between plants and air purification, while focusing research more towards climate-neutral processes

Matthias Zachert, chairman of the management board, said that this make Lanxess “an even more sustainable partner for our customers in the future” but also made business sense by saving costs through more efficient use of resources. However, the right policies need to be in place if the Paris Accord target of keeping average temperature increases to 2ºC or less is to be achieved. In particular, Zachert said, the German government should not jeopardise industry’s competitiveness by imposing a double burden of a national emissions trading scheme on top of the European one, as its ‘climate package’ currently proposes to do.

Separately, Lanxess Organometallics has agreed to sell its organotin specialities product line, comprising organotin catalysts and specialties plus intermediates, to the New Jersey based-PMC Group. Terms were not disclosed and the deal should close by the end of 2019. Lanxess will continue to manufacture certain products for PMC at Bergkamen in Germany under a tolling agreement.

Lanxess has also sold its 74% stake in a chrome ore mine in Rustenburg, South Africa to local firm Clover Alloys for an undisclosed amount. This should be completed by the end of 2020, subject to regulary approvals. The company described this as part of its ongoing focus on speciality chemicals. It had earlier agreed to sell its chrome chemicals business to Brother Enterprises of China.

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Axplora's site at Vizag

Axplora expands in India

Axplora has announced a “significant” investment at its site in Vizag, India (pictured)

Submitted by:

Andrew Warmington

Regis' headquarters in Chicago

Esteve acquires Regis

 

Barcelona-based Esteve Química has acquired Regis Technologies, a hitherto privately owned CDMO headquartered in Chicago

Submitted by:

Andrew Warmington

Meribel's facility at Uppsala

Ofichem buys site in Sweden

Netherlands-based CDMO Ofichem has acquired Meribel Pharma Solutions’ former Recipharm site in Uppsala, Sweden, which

Submitted by:

Andrew Warmington

Nippon Shokubai's API Facility in Japan

Nucleic acid API boost

Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

Submitted by:

Andrew Warmington

Flamma's facility in Dalian

Flamma opens in China

Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where

Submitted by:

Andrew Warmington

Afyren Neoxy plant

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

Origin by Ocean derives its materials from sargassum

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU

Submitted by:

Andrew Warmington

Ribbon cutting ceremony at Lubrizol's new office

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable

Submitted by:

Andrew Warmington

REACH Authorisation

Candidate List ‘reaches’ 250

The European Chemicals Agency (ECHA) has added three more substances to the Candidate List of

Submitted by:

Andrew Warmington

Staff at Brenntag's newly acquired Czech site

CO2-free distribution site first

Brenntag has officially inaugurated what it claims to be the first CO2-emission-free chemical distribution site

Submitted by:

Andrew Warmington